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Abstract
Nocturnin is a member of the CCR4 deadenylase family, and its expression is under circadian control with peak levels at
night. Because it can remove poly(A) tails from mRNAs, it is presumed to play a role in post-transcriptional control of
circadian gene expression, but its target mRNAs are not known. Here we demonstrate that Nocturnin expression is acutely
induced by the endotoxin lipopolysaccharide (LPS). Mouse embryo fibroblasts (MEFs) lacking Nocturnin exhibit normal
patterns of acute induction of TNFa and iNOS mRNAs during the first three hours following LPS treatment, but by 24 hours,
while TNFa mRNA levels are indistinguishable from WT cells, iNOS message is significantly reduced 20-fold. Accordingly,
analysis of the stability of the mRNAs showed that loss of Nocturnin causes a significant decrease in the half-life of the iNOS
mRNA (t1/2=3.3 hours in Nocturnin knockout MEFs vs. 12.4 hours in wild type MEFs), while having no effect on the TNFa
message. Furthermore, mice lacking Nocturnin lose the normal nighttime peak of hepatic iNOS mRNA, and have improved
survival following LPS injection. These data suggest that Nocturnin has a novel stabilizing activity that plays an important
role in the circadian response to inflammatory signals.
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Introduction
Living organisms require dynamic changes in protein compo-
sition to correspond to changes in the environment. Some of these
changes are unpredictable – such as exposure to pathogens or
toxins, while others are predictable – such as the daily cyclic
changes in light levels and nutrient availability. Many types of
acute signaling systems are in place to mediate the biological
responses to the former, while the circadian system regulates the
response to the latter, driving daily temporal changes in protein
type and quantity to allow the organism to coordinate physiolog-
ical events with time of day. In addition, interactions between the
systems also occur since some acute responses can alter the
circadian system, and the circadian system can cause changes in
the magnitude and types of acute responses at different times of
day. Although transcriptional changes are important for both types
of response systems, it has become increasingly clear that post-
transcriptional mechanisms play a critical role in dictating the
protein complement of the cell. Indeed, tight control of RNA
stability and/or translatability provides a way to rapidly modulate
responses and quickly terminate protein production.
Nocturnin is a deadenylase, a 39 exoribonuclease with specificity
for tracts of poly(A), that is under both circadian and acute
regulation. Identified originally as a rhythmic mRNA in Xenopus
retina [1,2,3], it is expressed with high amplitude rhythms in many
tissues in mice with peak levels at night [4,5]. In addition to this
circadian expression, it is also acutely inducible by a number of
stimuli, exhibiting immediate early gene responses [6]. Mice
lacking this gene have a metabolic phenotype, resistance to diet-
induced obesity, and changes in rhythmic expression of metabolic-
related genes in several different tissues/cell types [7]. Therefore,
based on Nocturnin’s known activity and expression pattern, our
working hypothesis is that Nocturnin is involved in the post-
transcriptional regulation of both rhythmic and acutely inducible
mRNAs. However the specific target mRNAs upon which
Nocturnin acts are not known.
Deadenylation, or poly(A) tail removal, is a rate-limiting and
highly regulated step in the mRNA decay pathway, and also can
regulate translatability of the message [8,9,10]. Nocturnin is a
member of the CCR4 family of deadenylases, of which there are 5
in mice and humans [11,12]. A single Ccr4p protein exists in yeast
and interacts with Caf1p/Pop2p proteins as part of the Ccr4-Not
complex – the major deadenylase in yeast [13,14,15]. In mammals,
the members of this family all contain a conserved Mg
++-dependent
nucleasedomainsimilartothat found inyeastCcr4p and typified by
the apurinic/apyrimidinic endonuclease (APE) family of proteins
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‘‘Ccr4b’’ in humans) have N-terminal extensions that contain
leucine-rich repeats like those necessary for the Caf1p/Pop2p
interaction in yeast. The other three members, including Nocturnin
(also known as ‘‘hCcr4c’’ in humans) are shorter, lacking these N-
terminal domains. One ofthese shortCcr4s inhumans(hCcr4d) has
beenshowntobepartofan‘‘unconventional’’deadenylasecomplex
foundinnuclearCajalbodies[12]and ithasbeenproposedbythese
authorsthat the othershortCcr4s mayalsohavediverged to take on
specialized functions. Although recombinant mouse Nocturnin has
been shown to possess bona fide deadenylase activity [6], the in vitro
activity is not robust compared to other deadenylases, and the
human Nocturnin has been reported to lack activity, at least within
the conditions of the in vitro assays and using generic substrates [12].
Because Nocturnin is an immediate early gene, and its
expression is up-regulated by many acute stimuli [4,6], we
examined the promoter region of the Nocturnin gene to identify
the in vivo signals responsible for Nocturnin’s acute induction. This led
us to the discovery of multiple nuclear factor-kappa B (NF-kB)
sites, indicating Nocturnin might be induced in response to
inflammatory signals. Since many mRNAs involved in the
inflammatory response are highly regulated and under post-
transcriptional control, we used a candidate approach to explore
whether Nocturnin expression altered the stabilization of these
transcripts. This led to the surprising discovery that the presence of
Nocturnin stabilizes the pro-inflammatory transcript, iNOS, rather
than destabilizing it. This results in significant in vivo changes in
iNOS expression profiles that may impact how the circadian clock
modulates the inflammatory response of the animal.
Results
Nocturnin is induced by LPS
Nocturnin has been shown to be rapidly induced in response to
various acute signals in culture, but in vivo signals that induce
Nocturnin are not well characterized [6]. We analyzed the
genomic regions 10 kb upstream from the murine and human
Nocturnin translation start sites to identify putative enhancer sites
that may regulate Nocturnin’s acute induction. This analysis
revealed many sequences with high similarity to canonical NF-
kB transcription binding sites (Figure 1A). Since NF-kB is a central
regulator of inflammatory responses, we investigated whether
lipopolysaccharide (LPS), could induce Nocturnin expression.
Indeed, we observed a 5–6 fold induction of the Nocturnin mRNA
and a 3-fold increase in Nocturnin protein levels in mouse
embryonic fibroblasts (MEFs) within 3 hours following LPS
treatment (Figure 1B–C).
Nocturnin is necessary for the normal accumulation of
iNOS protein following LPS stimulation
The observation that Nocturnin is induced by LPS led us to
investigate whether Nocturnin plays a role in regulating the LPS-
induced inflammatory response. To do this, we examined the
induction profiles of TNFa and iNOS, two known LPS-responsive
mRNAs, in wild-type (WT) and Noc KO MEFs. Both of the
mRNAs showed significant induction by LPS after 3 hours in both
the WT and Noc KO MEFs, and this induction was not
significantly different between genotypes (Figure 2). By 24 hours
after LPS treatment, the mRNA levels of TNFa decreased in both
WT and Noc KO cells, returning nearly to basal levels (Figure 2A).
In contrast, although the iNOS mRNA continues to rise in the WT
cells over 24 hours, it was nearly undetectable in the Noc KO cells
(Figure 2B). The Noc KO cells also had undetectable levels of the
iNOS protein 24 hours following LPS, in contrast to the high
levels observed in the WT cells at that time point (Figure 3A). To
verify that the loss of iNOS induction in the KO MEFs was due
solely to the lack of Nocturnin, we expressed heterologous
Nocturnin protein in the Noc KO cells. Nocturnin expression
was sufficient to rescue iNOS protein induction by LPS, and did so
in a dose-dependent manner (Figure 3B). This indicates that
Nocturnin is necessary for the normal accumulation of iNOS
protein following LPS stimulation in MEFs.
Figure 1. Nocturnin is induced by LPS in MEFs. (A) Putative NF-kB enhancer sites located in conserved regions in the Nocturnin gene and
flanking sequence. Human and mouse genomic sequences spanning 10 Kb upstream of the Nocturnin gene were aligned and analyzed by
Matlnspector [48]. Shown are relative positions of predicted conserved NF-kB binding sites (black boxes) near the mouse Nocturnin gene. +1 denotes
transcription start site and negative and positive numbers denote nucleotide position within the mouse sequence relative to that site. (B,C) MEFs
treated with LPS for indicated times were collected for total RNA isolation and protein extraction. iNOS mRNA levels were determined by quantitative
RT-PCR and normalized to Gapdh mRNA level. Data represent mean (6SEM) of three independent MEF lines. (B). NOC protein levels were determined
by Western blotting and normalized to Tubulin. The fold changes of NOC protein at different time points are indicated (C).
doi:10.1371/journal.pone.0026954.g001
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Nocturnin has deadenylase activity in in vitro experiments,
removing 59adenosine monophosphates from the 39 end of
polyadenylated substrates [Figure 4A; [1,6]]. Removal of the poly
(A) tail from transcripts typically alters the stability of the mRNAs,
causing them to degrade more rapidly. To determine whether
Nocturnin influences the iNOS mRNA half-life, we treated WT
and Noc KO MEFs with LPS for 3 hours to induce iNOS mRNA
and then blocked transcription with the addition of Actinomycin D
and collected samples at different intervals to measure mRNA
stability. In these experiments, we saw a clear and surprising effect
of Nocturnin on the half-life of iNOS mRNA (Figure 4B). The iNOS
mRNA was significantly less stable (t1/2=3.3 hours vs. 12.4 hours)
in the MEFs lacking Nocturnin, suggesting that the presence of
Nocturnin has a stabilizing effect on iNOS message. In the Noc KO
MEFs we did not observe any change in the half-lives of TNFa
mRNA (Figure 4C) or b-catenin (Figure 4D), a message unrelated to
the inflammatory response, indicating that the Nocturnin-
dependent stabilization of iNOS is transcript specific and is not a
general effect.
Nocturnin does not localize in mRNA-storage
cytoplasmic subdomains or polysomes
Considering that the deadenylase CCR4a/b can localize to
processing bodies (P-bodies; [16,17]), that a number of transla-
tionally silenced mRNAs can be stored in a deanylated form in P-
bodies or stress granules —two cytoplasmic subdomains that are
important for RNA storage, decay, and translational silencing
[18,19], and that the stabilized iNOS mRNA may be stored in
those foci, we analyzed whether Nocturnin localizes to some of
these structures. However, Nocturnin does not colocalize with
markers of stress granules or P-bodies (Figure 5A). Additionally,
we hypothesized that Nocturnin may deadenylate the iNOS
mRNA in polysomes, inducing changes in its translational status,
but polysome analysis demonstrated that Nocturnin is not present
in polysomes (Figure 5B). This implies that Nocturnin may be
functioning outside of the known mRNA processing pathways.
Nocturnin regulates iNOS rhythmicity
We next examined whether Nocturnin controls iNOS levels in
vivo by measuring the levels of iNOS mRNA in WT and Noc KO
mouse livers, a tissue which expresses iNOS and in which
Nocturnin shows a very high amplitude rhythm of expression
[Figure 6A; [5]]. Analysis of the circadian profile of basal iNOS
mRNA revealed high amplitude rhythms in the liver with peak
levels occurring during the late night, when Nocturnin protein is
highest (Figure 6B). In Noc KO mice, however, this rhythm is lost,
demonstrating that Nocturnin protein is necessary for the
nighttime accumulation of the iNOS mRNA (Figure 6C).
Nocturnin is involved in the in vivo response to LPS
challenge
LPS-induced endotoxic shock, is widely used as a model of the
inflammatory responses [20,21,22,23,24] and therefore, to further
explore whether Nocturnin is involved in regulating an inflam-
matory response in vivo, we examined the survival rate of WT and
Nocturnin KO mice following injection with LPS. Blind subjective
scoring of ‘‘sickness,’’ 24 hours following the injection, demon-
strated that the WT mice were significantly more adversely
affected by the LPS injection than were the KO mice (Figure 7A).
This genotype-specific difference continued for several days, with
decreased ‘‘survival’’ in the WT mice (see Methods: Figure 7B).
Discussion
We have shown that the stability of iNOS mRNA is regulated by
the circadian deadenylase Nocturnin, and we have demonstrated
that Nocturnin is necessary for the circadian rhythm of iNOS
mRNA levels in the liver. Our data suggest that the iNOS
rhythmicity is a result of a stabilization of the iNOS mRNA by
Nocturnin during the night when Nocturnin levels are high.
Regulation of iNOS at the level of mRNA stability has been
described in many contexts including hepatocytes and Kupffer
cells of the liver [25,26]. The 39UTR of the iNOS transcript
contains several AU-rich elements (AREs) and several ARE-
binding proteins have been shown to bind to these elements,
including HuR, AU-binding factor 1/heterogeneous nuclear
ribonucleoprotein D (hnRNP D), and KSRP [27,28,29]. Addi-
tionally, several other RNA binding proteins such as hnRNP I/
polypyrimidine tract-binding protein (PTB) and hnRNP L also
have been shown to interact with other regions of the iNOS 39UTR
and contribute to its proper post-transcriptional control
[27,30,31]. In hepatocytes, iNOS mRNA levels are also regulated
by a fascinating mechanism in which a natural antisense transcript
of the iNOS gene interacts with the iNOS message, forming a direct
Figure 2. iNOS mRNA is induced by LPS, but does not
accumulate in Noc KO MEFs. MEFs treated with LPS for the
indicated times were collected for total RNA isolation. mRNA levels of
TNFa (A) and iNOS (B) were determined by quantitative RT-PCR and
normalized against b2 microglobin. Data represent mean (6SEM) of
three independent MEF lines and comparison between genotypes at
each time point was done by two-way ANOVA followed by Bonferroni
post tests (Prism). N.S.=no significant difference between genotypes
(p.0.05).
doi:10.1371/journal.pone.0026954.g002
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[32].
Why does the loss of Nocturnin shorten the half-life of the iNOS
mRNA? Deadenylation is generally thought to be an important
regulatory step for targeting a message for degradation [8,9], and
yet loss of the Nocturnin deadenylase causes the iNOS mRNA to
degrade more rapidly, calling into question Nocturnin’s in vivo role.
However, our data do not discriminate between direct and indirect
effects of Nocturnin on the iNOS message, and it is possible that
Nocturnin is destabilizing some other message that encodes an
iNOS destabilizer. However, the recent observation that many
RNAs can exist in stable, but short-tailed forms [33] suggests that
the role of deadenylation may be more complex than previously
thought. Nevertheless, we have shown that Nocturnin does not
localize to known RNA storage compartments such as stress
granules or P-bodies, and is not present in polysomes. Also, loss of
Nocturnin in MEFs results in loss of both iNOS mRNA and iNOS
protein, suggesting that Nocturnin does not simply convert the
iNOS message into a stable short-tailed but translationally silent
form.
It is possible that Nocturnin competes with other more robust
deadenylases for certain target mRNAs. In in vitro assays,
Nocturnin has a less robust activity than other deadenylases such
as PARN [6], although there are many caveats in interpreting such
assays with generic substrates and isolated enzymes. Perhaps a
‘‘slow’’ or inefficient deadenylase protects messages from rapid
deadenylation and subsequent decay. Repeated attempts to
measure the poly(A) tail lengths of the iNOS mRNA in our Noc
KO cells were unsuccessful due to the extremely low levels of iNOS
message. But support for such an idea comes from analysis of the
CCR4 family members in humans where the ‘‘yeast-like’’
members with the extended leucine-rich N-terminal domains
(CCR4a and CCR4b) have robust deadenylase activity while the
other members, including Nocturnin, do not. One of the members
of this latter class, Ccr4d, was shown to participate in a
deadenylation complex in nuclear Cajal bodies [12]. Perhaps
Nocturnin has diverged to take on a role that stabilizes mRNAs,
either through its deadenylase activity or some other unknown
activity.
Recent reports have shown that the circadian clock modulates
the innate immune system in physiologically important ways
[34,35]. Both the clock and the immune system are under
significant post-transcriptional control [36,37,38,39] although the
inflammatory system has been much more extensively studied in
this regard. Many mRNAs that encode inflammatory response
proteins have short half-lives and this instability is necessary to
avoid accumulation of potentially harmful protein products in
times when they are not needed [39]. Our data strongly suggest
that Nocturnin plays an important role in stabilization of the
hepatic iNOS message both following LPS stimulation and during
the night within the circadian cycle.
Why are the basal levels of iNOS mRNA rhythmic in the liver?
Perhaps this is related to a circadian change in susceptibility to
inflammatory signals. It has been reported that mice exhibit
significantly higher lethality to LPS and TNFa administration
during their resting phase (day) and that this rhythm is under
circadian control [40,41]. Our demonstration that mice lacking
Nocturnin exhibit higher survivability following LPS injection
Figure 3. Accumulation of iNOS protein following LPS requires
Nocturnin. (A) iNOS protein is reduced in Noc KO MEFs following LPS
treatment. WT and Noc KO MEFs treated with LPS for twenty-four hours
were collected for protein extraction. Proteins were analyzed by
Western blotting with a-iNOS antibody (a representative blot is shown
in top panel) and protein levels were determined (normalized to b-
tubulin levels) and plotted as mean (6SEM) of three independent MEF
lines (bottom panel). (B) Expression of Nocturnin in Noc KO MEFs
rescues the LPS induction of iNOS protein. Noc KO MEFs were
electroporated with either empty FLAG vector (control) or a vector
expressing a FLAG-Nocturnin fusion protein (NOC-FLAG). Forty-eight
hours after electroporation, MEFs were treated for 24 hours with LPS
and were then collected for protein extraction. Proteins were analyzed
by Western blotting with a-iNOS and a-FLAG antibodies. Shown are
extracts expressing two different levels of NOC-FLAG (compare lanes 3
and 4, top blot), which correlate with the level of rescued iNOS protein
(compare lanes 3 and 4, bottom blot). The arrowhead marks a non-
specific band (this band is not iNOS, as it is still present in samples from
iNOS knockout mice, data not shown). The data shown are from two
independently-derived WT and two independently-derived KO MEF
lines (one per lane). This experiment was also repeated in a third
independent MEF line for each genotype with similar results (data not
shown).
doi:10.1371/journal.pone.0026954.g003
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sensitivity. Whether this resistance to LPS is due to the changes we
observe on iNOS stability is not yet known and further studies will
be required to more carefully examine other aspects of the innate
immune response in the Noc KO mice, and to determine whether
other inflammatory signals may also be Nocturnin targets.
Materials and Methods
Plasmids
To generate the Noc-FLAG construct, annealed oligos encoding
three copies of FLAG tag were inserted between XhoI and SalI
sites of a pCMV-Tag4A vector (Stratagene). The mouse Nocturnin
cDNA was then subcloned into the EcoRI and XhoI sites. Mouse
Noc (GenBank Accession Number AF199491) was cloned in a
pDEST15 vector (Invitrogen) for Escherichia coli expression with an
N-terminal GST-tag. pE-eGFP-G3BP1 plasmid was a generous
gift of Dr. Nancy Kedersha and Dr. Paul Anderson.
Antibodies and Western blot
The custom a-Nocturnin antibody was raised in rabbits (using
services provided by Sigma Life Sciences) against a recombinant
mouse Nocturnin protein (NP_033964) starting from the amino
acid 65 (methionine). The Ribosomal P antigen antibody was
obtained from ImmunoVision, the a-FLAG antibody, the a-
Tubulin antibody and the a-GE-heds antibody were obtained
from Sigma and the a-iNOS antibody was purchased from Santa
Cruz Biotechnology. All western blot signals were quantified by
the Storm 820 Phosphorimager (GE Healthcare Life Sciences).
Animals
WT and Noc KO (C57BL/6J background) mice were
maintained under a 12:12 h light-dark cycle with free access to
food and water. For circadian profiles of protein and mRNA, liver
tissue was collected at 4 hour intervals over 24 hours, dark time
points were collected using infrared goggles.
LPS treatment
Mice were injected intraperitoneally with 10 mg/kg body
weight of LPS (Sigma) at ZT4. The ‘‘sickness’’ score and survival
rate of mice were monitored for 5 days after LPS injection, and the
experiment was terminated when all the animals alive had a score
less than 3. The ‘‘sickness’’ scores were tallied with the observation
time point (24 hours after LPS injection) according to the criteria
listed below. All scoring was done ‘‘blind’’ with genotypes
unknown to the scorer.
All LPS experiments were carried out under the supervision of
veterinary staff,, and with the approval of the IACUC committee
at University of Virginia. The number of animals in the procedure
was kept to the smallest number necessary to obtain statistical
confidence in the replicability of the results (WT 6 mice, KO 12
mice). We chose a commonly used dose (10 mg/kg body weight;
Figure 4. Nocturnin alters iNOS mRNA half-life. (A) Nocturnin-mediated deadenylation releases 59AMP. Recombinant GST-NOC protein was
incubated with an RNA substrate containing a 100 nt poly(A) tail labeled with [a-
32P] -ATP at 37uC for 30 min. The radiolableled product of the
reaction was determined by two-dimensional thin layer chromatography analysis as described in the Materials and Methods. The dotted line denotes
the position of the cold 59AMP marker. (B–D) The stability of the iNOS mRNA (B), but not TNFa (C)o rb-catenin (D) is significantly reduced in the MEFs
lacking Nocturnin. MEFs were treated with LPS for 3 hours before the experiment. At time 0, LPS was removed and replaced with media containing
actinomycin D and cells were collected for RNA isolation at the times indicated. mRNA levels were determined by quantitative RT-PCR and normalized
against Gapdh mRNA. In each case, the mRNA level at time 0 was set as 100% and data were plotted as mean (6SEM) of 4–6 independent MEF cell
lines for each genotype.
doi:10.1371/journal.pone.0026954.g004
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pain and distress that animals might suffer, as well as for assessing
the severity of the inflammatory response, a humane endpoint was
determined by a small pilot study following the guideline of the
IACUC committee in University of Virginia. The mice were
monitored twice daily and softened food pellets were placed on the
cage floor for easy access. A ‘‘sickness’’ score (see below) was given
to each mouse during each monitoring session, and all scoring was
done ‘‘blind’’ with genotypes unknown to the scorer. To prevent
unnecessary suffering, any animal with a score of 8 or higher, and
any mice with 2 or more maximum scores (in any category) were
euthanized. These euthanized animals are included in the ‘‘dead’’
category in the survivability curve. The ‘‘sickness’’ score and
survival rate of mice were monitored for 5 days after LPS
injection, and the experiment was terminated when all the animals
alive had a score less than 3. The ‘‘sickness’’ scores were tallied
with the observation time point (24 hours after LPS injection)
according to the criteria listed below.
Sickness Scoring:
Body Weight Changes: 0=normal; 1=,10% weight loss;
2=10–15% weight loss; 3=.20% weight loss.
Physical Condition, Haircoat: 0=normal, well-groomed;
1=rough haircoat; 2=rough coat, hair loss, un-
groomed.
Physical Condition, Eyes and Nose: 0=normal; 1=eyes
closed or squinted, no discharge; 2=eyes closed or
squinted, discharge or porphyrin staining
Behavior, Activity: 0=normal; 1=decreased activity,
locomotion after slight stimulation; 2=inactive, less
alert, locomotion after moderate stimulation; 3=self-
mutilation, either very restless or immobile, or no
locomotion after moderate stimulation.
Behavior, Posture: 0=normal; 1=sitting in hunched up
position; 2=hunched posture/head on cage floor;
3=lying prone on cage floor.
Figure 5. Subcellular localization of Nocturnin protein. (A) Nocturnin protein does not co-localize with stress granules (SGs) or P-bodies (PBs).
NIH3T3 cells were transfected with NOC-FLAG only (arsenite-induced SG and PB experiments) or pE-eGFP-G3BP1 and NOC-FLAG (G3BP1-induced SG
experiments) constructs. Specific antibodies were used to detect NOC-FLAG and GE-heds (marker for P-bodies). Part of the image was amplified on
the right to more clearly show the lack of overlap. Shown are representative examples from 3 independent experiments. (B) Nocturnin protein does
not co-localize with polysomes. Polysome analysis was conducted by sucrose gradients. EDTA or cycloheximide was utilized to disassociate or freeze
the polysomes, respectively. Fractions were collected and separated by SDS-PAGE and analyzed by Western blotting. Tubulin and ribosomal P
antigen were blotted as markers of non-polysome fractions and ribosome/polysome fractions, respectively. This fractionation was performed on two
independent occasions with indistinguishable results.
doi:10.1371/journal.pone.0026954.g005
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Primary cultures of MEF cells from WT and Noc KO mice were
made as described in [42] and maintained in MEF media (DMEM
supplemented with 10% FBS, MEM nonessential amino acids,
2 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 20 mM HEPES,
pH7.3, and antibiotic-antimycotic mix solution). For LPS
experiments, asynchronous MEFs were cultured in MEF media
without FBS and phenol red for 18 hours before LPS treatment
and then replaced with fresh media containing 5 mg/ml of LPS for
indicated times. For mRNA decay experiments, MEF media
(without FBS and phenol red) containing 1 mg/ml of actinomycin
D was added upon the removal of the LPS media. For protein
analysis, cells were lysed in T-PER buffer (Pierce) with protease
inhibitor cocktail (Sigma) 24 hrs after LPS addition. Rescue
experiments were conducted by electroporating Noc KO MEFs
with NOC-FLAG or FLAG only expression vectors using a MEF1
nucleofector kit (Lonza). Forty-eight hours after electroporation
MEFs were treated for 24 hours with LPS as described above and
collected for protein extraction. Proteins were analyzed by western
blotting with a-iNOS and a-FLAG antibodies.
Quantitative reverse transcriptase PCR
Total RNA was isolated using Trizol reagent according to the
manufacturer’s protocol (Invitrogen) and reverse transcribed using
random primers. The quantitative RT-PCR reaction was
conducted with either SYBR Green (Invitrogen) or Taqman gene
expression assay (ABI). The relative expression of indicated RNAs
was normalized to an internal control using the DCt method (Gapdh
or b2-microglobin) or DDCt as described by the ABI protocol
respectively. Primers for iNOS, b-Catenin, b2-microglobin, and Gapdh
are obtained from Harvard Primer Bank and the sequences
are: Noc 59-ACCAGCCAGACATACTGTGC-39,5 9-CTTGGG-
GAAAAACGTGCCT-39; iNOS 59-GTTCTCAGCCCAACAA-
TACAAGA-39,5 9-GTGGACGGGTCGATGTCAC-39; b-Cate-
nin 59-AGTTTCCTATGGGAACAGTCG-39,5 9-AGGTTCAC-
TAGAACATAACACT-39; b2-microglobin 59-TTCTGGTGCTT-
GTCTCACTGA-39,5 9-CAGTATGTTCGGCTTCCCATTC-
39; Gapdh 59-AGGTCGGTGTGAACGGATTTG-39,5 9-TGTA-
GACCATGTAGTTGAGGTCA-39. Taqman primer sets were
purchased from Applied Biosystems: TNFa-Mm00443258_m1;
iNOS- Mm00440485_m1; b2-microglobin- Mm00437762_m1.
In vitro deadenylase assay and two-dimensional thin
layer chromatography
The deadenylase assay was carried out as described previously
[1,6,43,44]. The RNA substrate was synthesized from the G52
plasmid containing the last 86 nt of the b-globin 39UTR followed
by a 100 nt poly(A) tail. Radiolabeled RNA substrate was
synthesized by transcribing BamHI linearized DNA constructs
with SP6 polymerase (GIBCO-BRL) in the presence of [a-
32P]-
ATP (800 Ci/mmol, Perkin Elmer) and 625 mMo fa5 9 GpppG
cap analog (Amersham Pharmacia Biotech). Resulting RNA
products were separated on 6% polyacrylamide/7 M urea gels
and eluted in TNES buffer (0.1 M Tris-HCl pH 7.5, 0.3 M NaCl,
0.01 M EDTA, 2% w/v SDS) overnight at room temperature.
GST-Noc (final concentration 0.026 mg/ml) was incubated with
Figure 6. Nocturnin regulates rhythmic expression of iNOS in
mouse liver. (A,B) Nocturnin mRNA and protein are rhythmic in
mouse liver. Mice were maintained on a 12:12 light-dark cycle, and liver
samples were collected at different times of day as indicated. ‘‘ZT’’ refers
to Zeitgeber Time (hrs), where ZT0 is defined as light onset and ZT12 is
defined as dark onset. (A) Nocturnin mRNA levels were determined by
quantitative RT PCR and normalized against b-2 microglobin.( B)
Nocturnin protein levels were determined by measuring the chemilu-
minesence density from three independent western blots (n=3 mice)
and plotted as mean6SEM. (C) iNOS mRNA level is rhythmic in WT, but
not in Noc KO, mouse livers. iNOS mRNA levels were measured in the
same samples described in (A) by quantitative RT-PCR and normalized
to b-2 microglobin. Data are presented as mean (6SEM) of 3–6 mice for
each time point. For all the curves, data from ZT0 was re-plotted as
ZT24 to improve visualization of the 24 hour cycle. Rhythmicity of
curves was determined by CircWave v1.4 software (http:/hutlab.nl; R. A.
Hut, University of Groningen).
doi:10.1371/journal.pone.0026954.g006
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32P]-ATP-labeled RNA (final concentration 0.015 mM-
0.18 mM) at 37uC for 30 min. 1 ml of the stopped reaction was
spotted on a PEI cellulose plate, and developed in 15:1:10
isobutyric acid:NH4OH:H2O as the first dimension solvent,
0.75 M KH2PO4 as the second dimension solvent. Cold 59AMP
were analyzed on the same plate as a marker, and the position of it
was determined under 254 nm UV light.
Polysome analysis
Polysome analysis was conducted as described previously [45].
For the EDTA group, NIH3T3 cells were harvested in polysome
extraction buffer (10 mM Tris-HCl, pH 7.4; 1% TritonX-100;
15 mM MgCl2; 0.3 M NaCl; 1 mg/mL Heparin) with 30 mM
EDTA. For the cycloheximide group, cells were incubated in
medium containing 0.1 mg/mL cycloheximide for 3 min before
harvesting and were collected in 1 ml of polysome extraction
buffer with 0.1 mg/mL cycloheximide. Sample was centrifuged at
12,0006ga t4 uC for 10 min and the supernatant was loaded on a
10–50% consistency sucrose gradient and centrifuged at
35,000 rpms at 4uC for 190 min in an SW41 rotor. The gradient
and fraction collection were done in a Gradient Station
(BioComp). Tubulin and ribosomal P antigen were blotted as
markers of non-polysome fractions and polysome fractions
respectively.
Immunocytochemistry
For Nocturnin subcellular localization, NIH3T3 cells were
transfected with NOC-FLAG only (arsenite–induced P-bodies) or
pE-eGFP-G3BP1 and NOC-FLAG (G3BP1–induced stress gran-
ules) constructs using Fugene6 transfection reagent (Roche). The
a-FLAG antibody (Sigma) and a-GE-heds (PB marker; Santa
Cruz) antibodies were used for staining. Immunodetection of stress
granules and P-bodies was conducted according to Kedersha and
Anderson [46].
Statistics
For Nocturnin mRNA induction, one-way ANOVA was used to
determine the induction. For iNOS mRNA two-way ANOVA
followed by Bonferroni post-tests were used to determine the
induction. For the mRNA half-life data, the Global Curve
Comparison (Prism) was used. For iNOS protein induction and
‘‘sickness’’ score comparison, we used two-tailed student’s T-test.
For circadian profiles, rhythmicity of curves was determined by
CircWave v1.4 software [http:/hutlab.nl; R. A. Hut, University of
Groningen; [47]] For survival curve comparison, we used Log-
rank (Mantel-Cox) test (Prism).
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